Philadelphia health officials have detected West Nile virus in mosquitoes near Pennypack Park, urging residents to take precautions against the disease. Symptoms to watch for include neurological issues, and medical providers have been alerted to test patients as the health department expects more positive cases.
A new study reveals alarming links between frequent gabapentin prescriptions for chronic low back pain and increased risks of dementia and mild cognitive impairment, especially in younger adults. Learn why monitoring is essential.
Nestor Montalvo, a retired NY cop, faced a life-threatening ischemic stroke that left him fighting for survival. After a critical hospital intervention, he shares his incredible journey of recovery and the lessons learned about life.
A groundbreaking study confirms that adult human brains can generate new neurons, settling a long-standing debate in neuroscience. This discovery could revolutionize our understanding of brain health and recovery.
Eric Dane bravely shares his ALS diagnosis on 'Good Morning America,' revealing the emotional toll and the support from his family as he faces this life-changing condition. Discover his inspiring journey and determination to fight.
The FDA has approved Lumipulse, the first blood test for diagnosing Alzheimer’s, offering a simpler and less invasive option compared to traditional methods like PET scans. Experts believe this could revolutionize care and research.
The FDA has approved the first blood test for Alzheimer's, allowing for earlier diagnosis and treatment with existing drugs. This groundbreaking development could significantly impact millions facing cognitive decline.
The FDA has approved the first blood test for Alzheimer's, allowing for earlier treatment with existing drugs. This innovative test measures protein ratios linked to the disease, promising better patient outcomes.
New research reveals that silencing hyperactive AgRP neurons in the brain could reverse type 2 diabetes without affecting weight or diet. This groundbreaking study challenges existing beliefs and points to new treatment avenues.
A new NIH-funded study reveals crucial protein changes in spinal fluid that may provide the first specific biomarkers for frontotemporal dementia (FTD), paving the way for earlier diagnosis and treatment options.
